l-carnitine and cancer cachexia: Clinical and experimental aspects. - Wikidata - awgldk - TriplyDB

l-carnitine and cancer cachexia: Clinical and experimental aspects.

l-carnitine and cancer cachexia: Clinical and experimental aspects.

http://www.wikidata.org/entity/Q37863019

about

Cachexia and pancreatic cancer: are there treatment options?Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling.Creatine, L-carnitine, and ω3 polyunsaturated fatty acid supplementation from healthy to diseased skeletal muscle.Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology.L-carnitine supplementation in patients with HIV/AIDS and fatigue: a double-blind, placebo-controlled pilot study.Effect of L-carnitine on exercise performance in patients with mitochondrial myopathy Efficacy of L-carnitine supplementation on frailty status and its biomarkers, nutritional status, and physical and cognitive function among prefrail older adults: a double-blind, randomized, placebo-controlled clinical trial.A review on the role of L-carnitine in the management of tamoxifen side effects in treated women with breast cancer.Introduction: What to Eat When You Can't Eat.l-Carnitine Supplementation in Older Women. A Pilot Study on Aging Skeletal Muscle Mass and Function.L-Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis

P2860

Q27026558-4CDF9475-ADD8-4D61-8538-E556F17075E3 Q33597307-01D40C8F-FF9A-4E30-A4C6-9B113E926626 Q34177044-A890E9BC-7843-46DC-A39F-336A42745140 Q34334313-08EAECFE-1D1A-44D7-A91B-7BBEDD69C232 Q35121171-C12A0206-C7A0-45FF-89BC-D08BA376725E Q35565254-C00CA3D4-A64E-4BF0-A819-B50D1290DFA5 Q37427021-4549B666-41A1-4C75-9F4A-CB08A16F0EE1 Q38171391-D0DEFB18-8B56-4DD1-A5C8-6FFC1E5C1EF3 Q42054690-FBFEF140-9877-4B12-9F41-678BC8D4CF5A Q51767739-3A307DA0-0989-480E-BCD1-B8FA4604EF32 Q58799829-EEC16D8B-4035-4228-9E3A-87808BB0106C

P2860

l-carnitine and cancer cachexia: Clinical and experimental aspects.

http://www.wikidata.org/entity/Q37863019

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 January 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

l-carnitine and cancer cachexia: Clinical and experimental aspects.

@en

l-carnitine and cancer cachexia: Clinical and experimental aspects.

@nl

type

label

l-carnitine and cancer cachexia: Clinical and experimental aspects.

@en

l-carnitine and cancer cachexia: Clinical and experimental aspects.

@nl

prefLabel

l-carnitine and cancer cachexia: Clinical and experimental aspects.

@en

l-carnitine and cancer cachexia: Clinical and experimental aspects.

@nl

P1433

Q37863019-830039A3-00B2-46E2-942A-B9AA4F77D0B8

P1476

Q37863019-9105FFB6-DB0C-4FF5-901A-42EB72FA81DB

P2093

Q37863019-0113A5C7-A815-4622-A20B-15B1721D3BAB

Q37863019-4B06C969-534D-4C90-99EF-73CE03347159

P2860

Q37863019-00B9AD4A-1308-448A-B3EA-94DE90F575BD

Q37863019-00E790E7-F28E-4622-9964-B0762BF2F64E

Q37863019-01330A66-9ED2-4713-9FC4-7EBAD89E47A8

Q37863019-023A4087-F087-4319-8EDF-438A16E0F3FE

Q37863019-04CD6754-D17E-488C-8099-445B14032E87

Q37863019-0666C2F5-81EA-4E59-8E5A-BFD84BA8F05A

Q37863019-099AAF6B-9494-4FFE-B93D-BCB1384F7C38

Q37863019-0A9DECA2-8692-4D40-8690-2CCD62D05E3F

Q37863019-0FECE638-97D1-47AD-8146-9645A046A563

Q37863019-11C795AC-3EE8-4253-A5F1-F873B39072DC

P304

Q37863019-0EA73750-FB91-4EBB-A019-DFA0553A6582

P31

Q37863019-5B7AA336-1D6D-44AC-BDBB-2688A69BE760

P356

Q37863019-CBFE834A-F39F-469E-87FF-D75478B0568E

P433

Q37863019-CBAD7A6D-08C4-4388-B73C-A3F5CCF698C3

P478

Q37863019-9CF96842-3786-4488-82E1-1BBACC774CC2

P50

Q37863019-C139B1DB-0419-4A6A-B463-50B531242432

Q37863019-E95784B0-D515-4C3C-A846-0637EF1CBDCC

P577

Q37863019-3AEE8A88-39A7-4AAD-9B16-AA572E78C648

P5875

Q37863019-E2B0D658-79E9-480D-A990-BB4450483FB4

P698

Q37863019-2B0CF539-639D-412A-8CE4-CDC9502EA3F1

P932

Q37863019-D03A2CCE-F72A-455F-AE88-2924DBD62CB3

P356

S13539-011-0017-7

P1433

Journal of Cachexia, Sarcopenia and Muscle

P1476

l-carnitine and cancer cachexia: Clinical and experimental aspects

@en

P2093

Alessandro Laviano

http://www.w3.org/2001/XMLSchema#string

Renata Silvério

http://www.w3.org/2001/XMLSchema#string

P2860

An overview of sarcopenia: facts and numbers on prevalence and clinical impact

Decreased Jun-D and myogenin expression in muscle wasting of human cachexia

Supplemental carnitine and exercise

Exhaustive exercise causes an anti-inflammatory effect in skeletal muscle and a pro-inflammatory effect in adipose tissue in rats

Cancer-related fatigue: guidelines for evaluation and management.

Increased neopterin concentrations in patients with cancer: indicator of oxidative stress?

Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system.

The cancer anorexia-cachexia syndrome.

Inhibition and stimulation of long-chain fatty acid oxidation by chloroacetaldehyde and methylene blue in rats.

Cachexia and anorexia: cancer's covert killer.

P304

37-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13539-011-0017-7

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Filippo Rossi Fanelli

Marília Seelaender

P577

2011-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51034845

http://www.w3.org/2001/XMLSchema#string

P698

21475677

http://www.w3.org/2001/XMLSchema#string

P932

3063878

http://www.w3.org/2001/XMLSchema#string